Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Single-port Robotic Retroperitoneal Nephroureterectomy with Lower Anterior Access: Surgical Technique, Perioperative and Early Oncological Outcomes from a Multi-institutional Series.

Created on 07 Nov 2026

Authors

Paolo Gontero, Federico Lavagno, Marco Oderda, Francesco Soria, Simona Ingrassano, Roberto Contieri, Gianluca Spena, Antonio Galfano, Paolo Dell'Oglio, Srinivas Vourganti, Riccardo Autorino, Gennaro Musi, Simone Crivellaro, Sisto Perdonà

Published in

European urology. Nov 06, 2026. Epub Nov 06, 2026.

Abstract

To describe lower anterior access single-port robotic radical nephroureterectomy (LAA-SP RNU), including bladder cuff excision (BCE) and lymph node dissection (LND), without repositioning or redocking.
We present a multicenter retrospective series of 47 patients with upper tract urothelial carcinoma who underwent LAA-SP RNU at five referral centers (May 2024-July 2025). A single 4-cm extraperitoneal incision enabled nephroureterectomy, BCE, and selective hilar/pelvic LND without repositioning or redocking. Data were evaluated using descriptive analyses, and pentafecta achievement for the full cohort was estimated through Kaplan-Meier analysis.
Median age of the patients was 72 yr; 95% had high-risk disease. LND was performed in 20 patients (43%). Median docking and operative times were 20 and 220 min, respectively; one procedure was converted to open surgery. Grade ≥3 complications occurred in three patients (6%); median hospital stay was 5 d. Pathology showed pT2 and pT3 disease in 15% and 36%, respectively. At median follow-up of 12.3 mo, seven patients (14.9%) experienced recurrence, including five intravesical recurrences; two died from metastatic disease. The 12-mo Kaplan-Meier estimate of pentafecta achievement was 76.7% (95% confidence interval, 62.8-90.5%). This study is limited by potential referral-center and patient-selection bias, heterogeneity in LND and postoperative management, limited follow-up, and the absence of cost-effectiveness data.
LAA-SP RNU appears feasible and associated with acceptable perioperative and early oncological outcomes in experienced centers. Comparative prospective studies with longer follow-up are needed to establish oncological durability, patient benefit, and cost-effectiveness.

PMID:
42995053
Bibliographic data and abstract were imported from PubMed on 07 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 20
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement